Lombard Medical Technologies Share Discussion Threads

[nigelsom] 21/4/2011 08:08

It's further down in the RNS - they clearly thought we either a) wouldn't notice the RNS or b) wouldn't notice the placing price.

[philo124] 21/4/2011 08:01

I ageree; where did you get the 0.7p?? from, couldn't see it in thr RNS.

[nigelsom] 21/4/2011 01:06

Hi, I'm new to this board.
My take is that a placing at 0.7p is a hell of a discount, and to announce it a 5.30 in the afternoon is really bad form.
That said, it does begin to look as though they will get their FDA approval, and if they do then shareholders will do just fine. It just annoys me that long termers take all the risk and city chums get in late on at a huge discount.
The better news seems to be that PIs can apply for some shares too. Have I got that right?

[philo124] 20/4/2011 23:11

Where in Andalucia?

[restassured] 20/4/2011 22:21

Have another line and you will be fine.After all, it is only grown men in shorts earning £150,000 a week, kicking a ball about.

Not bad work if you can get it.

[restassured] 20/4/2011 22:10

The fact is they managed to get two major shareholders to back them and if they get the FDA approval its blue sky.

What lane?

I am in Andalucia ,Spain.

[webshares] 20/4/2011 21:55

i don't know what to make of the results, positives all round pretty much and our future pretty much assured, well as long as we get we get fda approval.

i guess i'll wait and see what mr market thinks of it tomorrow.

great game at the lane tonight!

[restassured] 20/4/2011 19:36

Outlook, 2011 and Beyond

The sales growth seen in the UK during 2010 has demonstrated that Aorfix(TM), with its unique, flexible design which gives it the ability to treat the estimated 30% of AAA patients with tortuous anatomy, can take a significant share of the $1.1 billion worldwide EVAR market when fully approved, properly marketed and supported by a dedicated sales force.

The two-tranche fundraising announced today will give the Company the funds to replicate the highly successful UK model in other European countries and most importantly in the U.S. post FDA approval; to expand production capacity to meet anticipated demand; to complete the Aorfix(TM) development projects that will ensure the product remains competitive; and to resume development of the Company's thoracic stent graft.

The Directors believe that pursuing this strategy will lead to significant sales growth over the next few years and create significant shareholder value.

[stable] 20/4/2011 18:59

Webshares
Reults out after close today, with a large money raising. The results are improving but the new money required for the next 18 months is going to see the share price tumbling and possibly without good news remaining on the floor for some time.
I have not as yet got my head arond all the details , too many for an old un like me to take in
Help

[webshares] 15/4/2011 18:21

i know, something juicy must be going on, i guess we'll find out next week??? maybe

[stable] 15/4/2011 08:20

glad it was not today, there web site now says mid April, which I take as 10th to 20th. What are they waiting for to make the results more interesting?

[nod] 14/4/2011 22:50

Thursday the 21st then :)

[webshares] 14/4/2011 19:38

right tomorrow will be officially mid april. c'mon LMT sort it out. if results are bad i've got other places i can put this money..... not that i have a lot invested in here

[backmarker] 14/4/2011 16:25

or perhaps Friday ?

[nod] 12/4/2011 09:06

Results on Thursday I reckon :)

[restassured] 11/4/2011 18:07

Well the last co I have that delayed results just got taken over,so here's hoping for a double.At the very least some positive news.

[stable] 11/4/2011 17:51

web
hmmm agree with your comment, ? delaying results, why? covention ends today. could it be they needed it to end before making an announcement?. 2) have they had an interest in company and they want to be able to make announcement with results?
3) are they so short of staff that results have taken longer to put together than expected?

let us hope whatever reason they report soon

[webshares] 11/4/2011 17:00

early april ay???? hmmmmm

[webshares] 08/4/2011 16:49

up down up down. well at least it is more interesting than flat lining.

results monday then, after (hopefully) a great convention

[rayrac] 08/4/2011 13:36

Perhaps they are hanging back with the results in order to announce more than just figures?

Someone mentioned Invesco earlier, I think they might be bang on with their theory. They certainly must be in the driving seat and very interested in a bid for the co'.

Just a matter of time..........

[restassured] 08/4/2011 10:42

If they provide an optimistic outlook,the shares could double as quickly as they have halved.

[roundyg] 08/4/2011 08:02

Thanks Nod,

Must have missed that! If so, and the modules are fully assessed as they are received by the FDA, then FDA feedback is more likely to be in the 60-90 day region post submission of Module 6. Fingers crossed for all on it and hope the results look good :)

[nod] 07/4/2011 21:39

roundy - the fifth module was submitted in December 2010 ...

Published 13 December 2010
Lombard Medical Technologies, a medical device company focused on abdominal aortic aneurysm (AAA) repair market, has submitted the fifth of six pre-market approval (PMA) modules required for the approval of Aorfix by the US Food and drug Administration (FDA).

Lombard Medical had FDA permission to file the PMA for Aorfix in a series of 6 modules and the first three of the modules, on biological testing, non-clinical laboratory studies and sterilisation and packaging, have already been reviewed and accepted by the FDA.

The fourth module on bench testing and shelf life was submitted in November and the penultimate module on manufacturing has just been submitted and the final module containing the clinical data is expected to be filed in the first half of 2011.

Lombard Medical chief executive John Rush said they set out clear timelines for submission of the PMA modules required for FDA approval of Aorfix earlier this year and they remain firmly on track to achieve them.

"We look forward to submitting the final PMA module demonstrating the clinical evidence for the use of the Aorfix stent graft in the treatment of complex tortuous anatomy during the first half of 2011," Rush said.

[webshares] 07/4/2011 21:31

results tomorrow or monday then, time results with the convention